Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China
· Delayed Price · Currency is CNY 57.27
-0.73 (-1.26%)
Jun 4, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Pharmaceutical Research Services | 568.60M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Services Growth | 28.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalytical Services | 362.39M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalytical Services Growth | 54.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business | 1.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Business Growth | 436.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Service - Generic Drug Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Service - Generic Drug Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Generic Drug Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Generic Drug Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Service - Consistency Evaluation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Service - Consistency Evaluation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Consistency Evaluation | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Consistency Evaluation Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Innovative Drug Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Innovative Drug Development Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Clinical Trials and Bioanalysis Services - Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Research Service - Innovative Drug Development | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| China | 932.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 37.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|